Latest Metastatic urothelial carcinoma Stories
Exploratory Analysis Shows Addition of 600mg Apatorsen to Standard of Care Chemotherapy Resulted in 50 Percent Reduction in Risk of Death in Patients with Lower Performance Status Phase
The antiangiogenic drug pazopanib has demonstrated clinically meaningful activity in patients with refractory urothelial cancer.
A new study shows a combination treatment might be better than the drug gemcitabine at improving survival among patients with pancreatic cancer that has spread to other areas of the body.
The combination of two different chemotherapies and a previously approved treatment for kidney and liver cancers is not effective against advanced melanoma.
Novel chemotherapy and biological agents for metastatic colorectal cancer has resulted in increased patient survival, U.S. researchers say. Researchers at the University of Texas M.D.
TORONTO (Reuters) - Lorus Therapeutics Inc. said on Wednesday data from Phase 3 trials of its Virulizin(R) cancer treatment showed a significant survival benefit for a subgroup of patients.
- A transitional zone between two communities containing the characteristic species of each.